SCHEMBL573403

SCHEMBL573403

CCCCOC(=O)N1CCN(C(=O)C2CCC(Nc3cc(OCCN4CCCCC4)ncc3[N+](=O)[O-])CC2)C(C)C1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 4/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ROCK2 O75116 4/20 0.35
ROCK1 Q13464 4/20 0.35
GPR174 Q9BXC1 2/20 0.34
CYP4F2 P78329 1/20 0.34
HRH2 P25021 1/20 0.34
HRH1 P35367 1/20 0.34
MGLL Q99685 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15192982 0.89 ALDH1A1 (0.40) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL572209 0.89 ALDH1A1 (0.40) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL15192986 0.89 ALDH1A1 (0.40) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL573186 0.89 NSD2 (0.39) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL572235 0.89 NSD2 (0.39) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL573185 0.89 NSD2 (0.39) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL10270888 0.80 KDM4E (0.43) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL572765 0.80 KDM4E (0.43) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL571665 0.79 KDM4E (0.45) KDM4EMEN1KMT2AHTTALDH1A1
SCHEMBL10270106 0.79 NSD2 (0.44) KDM4EMEN1KMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611784-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE Amgen, Inc (US) 2013-07-10 EP disclosed
WO-2012018668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2012-02-09 WO disclosed